New York, New York (PRWEB) October 10, 2013
Thousands of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against Boston Scientific Corp. are moving forward in a multidistrict litigation now underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. On October 9th, the Court amended the litigation’s First Amended Docket Control Order which, among other things, sets forth deadline for certain matters involving discovery and motions practice for the proceeding’s first two rounds of bellwether trials. According to the Order, the first trial of a Boston Scientific vaginal mesh lawsuit will commence on March 10, 2014. (In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326)
“We are representing numerous women who have suffered serious vaginal mesh complications allegedly due to mesh devices marketed by Boston Scientific and other companies. We are pleased to see this litigation progressing, and look forward to the start of trials next year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing hundreds of women who allegedly suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to transvaginal mesh products marketed by a number of manufacturers. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in the Boston Scientific litigation.
Vaginal Mesh Lawsuits
Court documents indicate that more than 6,400 vaginal mesh lawsuits have been filed against Boston Scientific in the Southern District of West Virginia. The company is just one of several pelvic mesh manufacturers involved in litigations now underway in the same jurisdiction. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees for proceedings involving American Medical Systems, Inc. (MDL No. 2325), C.R. Bard, Inc. (MDL 2326) and Ethicon, Inc. (MDL No. 2327).
Court records indicate that the first bellwether trial in the federal C.R. Bard litigation concluded in the Southern District of West Virginia in September, with the jury awarding $2 million in compensatory and punitive damages to a woman who suffered complications after receiving the company’s Avaulta Plus device. (Cisson v. C.R. Bard Inc., 11-cv-00195)
Mr. Grand has also been named Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon transvaginal mesh lawsuits that are currently underway in New Jersey’s Atlantic County Superior Court. He was also a member of the trial team on the first Ethicon trial in that proceeding, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
According to court documents, all of the transvaginal mesh lawsuits pending in these proceedings allege that mesh products used to treat pelvic organ prolapse and stress urinary incontinence caused plaintiffs to suffer mesh erosion, chronic pain, infections and other life-altering vaginal mesh complications. Plaintiffs further allege that defendants failed to provide adequate warnings regarding the risks associated with these devices.
Transvaginal mesh lawsuits have been mounting since October 2008, when the U.S. Food & Drug Administration (FDA) warned that it had received more than 1,000 adverse event reports that detailed serious complications associated with vaginal mesh products over a three year period.* The FDA issued another alert in July 2011, noting that reports of vaginal mesh complications in women who had undergone prolapse repair had grown five-fold since its previous warning. Among other things, the FDA said it no longer considered these types of injuries to be rare.
Alleged victims of serious vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. Learn More about transvaginal mesh lawsuits at Bernstein Liebhard LLPs website. To arrange for a free legal consultation, please contact the Firm today by calling 800-511-5092.
*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm; FDA, October 2008
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP